Ensysce Biosciences (ENSCW) Shareholder's Equity (QoQ) (2018 - 2025)
Ensysce Biosciences (ENSCW) Shareholder's Equity (QoQ) (2018 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Ensysce Biosciences |
- |
- |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
139.72% |
| Sep 30, 2025 |
-60.68% |
| Jun 30, 2025 |
12.49% |
| Mar 31, 2025 |
-19.51% |
| Dec 31, 2024 |
-48.63% |
| Sep 30, 2024 |
344.76% |
| Jun 30, 2024 |
-56.75% |
| Mar 31, 2024 |
625.23% |
| Dec 31, 2023 |
-156.26% |
| Sep 30, 2023 |
-69.48% |
| Jun 30, 2023 |
2,588.33% |
| Mar 31, 2023 |
96.22% |
| Dec 31, 2022 |
37.25% |
| Sep 30, 2022 |
-705.18% |
| Jun 30, 2022 |
-171.77% |
| Mar 31, 2022 |
113.62% |
| Dec 31, 2021 |
-2,017.40% |
| Sep 30, 2021 |
-107.46% |
| Jun 30, 2021 |
170.75% |
| Mar 31, 2021 |
-9.69% |
